Literature DB >> 26069210

Reprogramming of B cell acute lymphoblastic leukemia cells: Do we need to shoot a moving target?

Karel Fišer1, Lucie Slámová1, Jean-Pierre Bourquin2, Jan Trka1, Jan Starý1, Ondřej Hrušák1, Ester Mejstříková3.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26069210      PMCID： PMC4500239          DOI： 10.1073/pnas.1508680112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  4 in total

1.  Human short-term repopulating stem cells are efficiently detected following intrafemoral transplantation into NOD/SCID recipients depleted of CD122+ cells.

Authors:  Joby L McKenzie; Olga I Gan; Monica Doedens; John E Dick
Journal:  Blood       Date:  2005-05-05       Impact factor: 22.113

2.  Reprogramming of primary human Philadelphia chromosome-positive B cell acute lymphoblastic leukemia cells into nonleukemic macrophages.

Authors:  James Scott McClellan; Christopher Dove; Andrew J Gentles; Christine E Ryan; Ravindra Majeti
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-16       Impact factor: 11.205

3.  CD2-positive B-cell precursor acute lymphoblastic leukemia with an early switch to the monocytic lineage.

Authors:  L Slamova; J Starkova; E Fronkova; M Zaliova; L Reznickova; F W van Delft; E Vodickova; J Volejnikova; Z Zemanova; K Polgarova; G Cario; M Figueroa; T Kalina; K Fiser; J P Bourquin; B Bornhauser; M Dworzak; J Zuna; J Trka; J Stary; O Hrusak; E Mejstrikova
Journal:  Leukemia       Date:  2013-11-25       Impact factor: 11.528

Review 4.  Human hemato-lymphoid system mice: current use and future potential for medicine.

Authors:  Richard A Flavell; Markus G Manz; Anthony Rongvaux; Hitoshi Takizawa; Till Strowig; Tim Willinger; Elizabeth E Eynon
Journal:  Annu Rev Immunol       Date:  2013-01-16       Impact factor: 28.527
  4 in total
  2 in total

1.  Reply to Fišer et al.: Myeloid reprogramming of Ph+ B-ALL: A potential therapeutic strategy.

Authors:  Ravindra Majeti; Christopher Dove; James Scott McClellan
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-11       Impact factor: 11.205

Review 2.  Cancer cell reprogramming: a promising therapy converting malignancy to benignity.

Authors:  Lanqi Gong; Qian Yan; Yu Zhang; Xiaona Fang; Beilei Liu; Xinyuan Guan
Journal:  Cancer Commun (Lond)       Date:  2019-08-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.